Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct 1;11(1):691.
doi: 10.1186/s13104-018-3789-4.

Non-adherence to anti-tuberculosis treatment, reasons and associated factors among TB patients attending at Gondar town health centers, Northwest Ethiopia

Habtamu Sewunet Mekonnen  1 , Abere Woretaw Azagew  2
Affiliations

Non-adherence to anti-tuberculosis treatment, reasons and associated factors among TB patients attending at Gondar town health centers, Northwest Ethiopia

Habtamu Sewunet Mekonnen et al. BMC Res Notes. .

Abstract

Objective: The aim of this study was to assess the prevalence of non-adherence to anti-tuberculosis treatment, reasons and associated factors among TB patients attending at Gondar town health centers.

Result: A total of 314 participants were included with the response rate of 97.5%. The mean age of participants was 35.94 (SD ± 13.83) years. The overall rate of non-adherence to anti-TB treatment was 21.2% (95% CI 17.2, 26.1). Continuation phase of treatment (AOR = 2.27, 95% CI (1.54, 5.94)), presence of more than one co-morbidity (AOR = 6.22; 95% CI (2.21, 17.48)), poor knowledge about TB and anti-TB therapy (AOR = 4.11; 95% CI 1.57, 10.75), poor patient-provider relationship (AOR = 4.60, 95% CI 1.63, 12.97), and alcohol intake (AOR = 5.03; 95% CI 1.54, 16.40) were significantly associated with non-adherence. Forgetting 40 (23.1%), Being busy with other work 35 (20.2%), and being out of home/town 24 (13.9%) were the major reasons of participants for interruption of taking anti-TB medications.

Keywords: Ethiopia; Non-adherence; Prevalence; Reasons; Tuberculosis treatment.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Reasons for interruption of taking anti-TB medications of participants attending TB clinic in health centers at Gondar town, Northwest Ethiopia, 2017 (n = 173)
See this image and copyright information in PMC

References

    1. Organization WH . Global tuberculosis report 2017. Geneva: World Health Organization; 2017.
    1. Organization WH. Multi drug resistant tuberculosis (MDR-TB) Uptodate WHO Global tuberculosis program; 2017.
    1. Organization WH . Global strategy and targets for tuberculosis prevention, care and control after 2015, the end TB strategy. Geneva: World Health Organization; 2015.
    1. Schiffman G. Tuberculosis, Test, causes, treatment and Prognosis. eMedicineHealth. https://www.emedicinehealth.com/tuberculosis/article_em.htm.
    1. Jain A, Dixit P. Multidrug resistant to extensively drug resistant tuberculosis: What is next? J Biosci. 2008;33:605–616. doi: 10.1007/s12038-008-0078-8. - DOI - PubMed

Substances